Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2025-04-01 Transaction in Own Shar…
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote
Transaction in Own Shares Classification · 85% confidence The document is a monthly update on Novacyt’s liquidity contract, detailing the share purchases and sales executed by Invest Securities on behalf of the company and the total number of voting rights. This falls under a report of transactions in the company’s own shares (share buyback/issuance) rather than an announcement of a broader report or financial results. Therefore, it matches the “Transaction in Own Shares” category (Code: POS).
2025-04-01 French
Liquidity Agreement and Total Voting Rights
Transaction in Own Shares Classification · 100% confidence The document is a monthly update regarding a liquidity agreement, detailing share purchases and sales by a third party (Invest Securities) on behalf of the company, as well as a disclosure of total voting rights. This type of disclosure regarding share buybacks and treasury shares falls under the category of 'Transaction in Own Shares' (POS).
2025-04-01 English
Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote" (Monthly information on the liquidity contract and total voting rights). It explicitly details the monthly activity (March 1 to March 31, 2025) under a liquidity contract (share buybacks/sales by the agent, Invest Securities) and reports the total number of voting rights as of March 31, 2025. This content directly relates to the company's share structure, insider/agent transactions concerning shares, and voting rights disclosure, which is a specific regulatory requirement often disclosed monthly or periodically. While it involves share transactions (similar to POS or DIRS), the primary focus is the mandatory monthly disclosure of the total voting rights denominator and the status of the liquidity agreement. This type of periodic disclosure, especially concerning voting rights and share capital structure updates outside of major corporate actions, fits best under the general category of regulatory updates or specific share/capital change reporting. Given the explicit mention of 'nombre total de droits de vote' and the monthly update on the liquidity contract (which involves share transactions), it is a specific regulatory disclosure. Since there isn't a specific code for 'Monthly Voting Rights/Liquidity Update', and it is a formal, periodic disclosure, it aligns closely with the nature of a 'Major Shareholding Notification' (MRQ) in terms of periodic disclosure frequency, or more broadly, a Regulatory Filing (RNS). However, the content is highly specific to share capital/voting rights disclosure, which is often grouped with share issues (SHA) or major holdings (MRQ). Since it is a mandatory disclosure about the total number of shares/votes (the denominator for major holdings), and it details transactions by the liquidity provider, it is a specific regulatory filing. Given the options, 'Major Shareholding Notification' (MRQ) is often used for disclosures related to the denominator used for calculating major holdings, making it the closest fit for a mandatory voting rights disclosure, although 'RNS' is a safe fallback. I will classify it as MRQ because the voting rights denominator is the key piece of information provided for shareholder calculations, which is the core function of MRQ-type disclosures.
2025-04-01 French
Mise à jour relative aux poursuites judiciaires lancées contre Lab 21 par le Health and Safety Executive (Direction de la santé et de la sécurité)
Legal Proceedings Report Classification · 98% confidence The document is a formal update from Novacyt S.A. regarding legal proceedings involving one of its subsidiaries (Lab 21) and the Health and Safety Executive (HSE). It details a guilty plea in court regarding historical health and safety breaches and mentions the upcoming sentencing hearing. This content directly relates to significant lawsuits or regulatory actions involving the company. Therefore, it fits the definition of a Legal Proceedings Report (LTR). Although it references a previous RNS announcement, the core content is the update on the legal case itself, not just the announcement of a report.
2025-03-18 French
Update re. Lab 21 HSE Prosecution
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number' and contains standard boilerplate language from RNS (the news service of the London Stock Exchange), including the closing statement: 'This information is provided by RNS, the news service of the London Stock Exchange.' The content itself is a brief update regarding a legal matter (HSE Prosecution) and mentions that a further announcement will be made following the sentencing hearing. Since this is a general, non-periodic, and non-financial-result-specific regulatory announcement that doesn't fit into specific categories like DIRS, DIV, or ER, it falls under the general regulatory filing category.
2025-03-18 English
Liquidity Agreement and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement disseminated via RNS (RNS Number: 1468Z) dated March 3, 2025. The content explicitly details a 'Liquidity Agreement Monthly Update' concerning share purchases and sales by a third party (Invest Securities) on behalf of Novacyt, and also provides the 'Total Voting Rights' figure. This type of announcement, which reports on treasury share movements under a liquidity agreement and updates the total share count for regulatory denominator purposes, is a routine corporate disclosure. It is not a full annual report (10-K), an earnings release (ER), or a management discussion (MDA). Since it reports on specific transactions involving the company's own shares (share repurchase/issuance activity under the agreement), it aligns closely with the definition of 'Transaction in Own Shares' (POS). However, the primary focus is the mandatory monthly update on the liquidity agreement and the total voting rights disclosure, which often falls under general regulatory reporting. Given the specific nature of reporting on share transactions under a liquidity agreement and the disclosure of total voting rights, it fits best under 'Transaction in Own Shares' (POS) or potentially a general 'Regulatory Filing' (RNS). Since the core activity described is the execution of share buybacks/sales under a standing agreement, POS is the most specific fit, although it also contains elements of a voting rights update. Because the document is a direct report of transactions (purchases and sales of ordinary shares) and the resulting treasury share balance, POS is selected over the broader RNS.
2025-03-03 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.